Webinar – Opportunities and challenges for pharma and biotech companies in 2021
In partnership with
Tuesday, February 23, 2021
8.00 am PT / 11.00 am ET / 4.00 pm GMT / 5.00 pm CET
Duration: 45 minutes
With a new administration in Washington, DC, we will see changes across government agencies – including the SEC and the Food and Drug Administration – as well as the potential for further tweaks to the US healthcare system. These factors, along with the Covid-19 vaccine rollout, raise a host of opportunities and challenges for pharmaceutical and biotechnology companies during 2021. In addition, the whole market continues to try to piece together the events of late January involving GameStop, AMC Entertainment and others, to ask whether it can happen again.
In this webinar we will examine how pharma and biotech companies can prepare for the year ahead – both in terms of regulatory changes and corporate access – and learn about retail IR strategies.
|Moderator: Ben Ashwell, editor, IR Magazine & Corporate Secretary|
|Annie Chang, head of investor relations, Sutro Biopharma|
|Nick Mazing, head of research, Sentieo|
Short, sharp and packed with expert insight, this webinar will get you up to speed on these critical issues in just 45 minutes. Sign up to BrightTALK to view this essential briefing and be informed of future webinars produced by IR Magazine.
|Holders of the NIRI IRC® credential can earn 1 professional development unit (PDU) per webinar. IRC-credentialed speakers may also earn PDUs. More information is available at www.niri.org/certification|